Ligand Pharma (LGND) Reports In-Line Q4 EPS; Issues Light Q1 Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to Ligand Pharma (LGND) Reports In-Line Q4 EPS; Issues Light Q1 Outlook
LIGAND PHARMA (NASDAQ: LGND) Delayed: 255.54 +0.97 (0.38%)
Previous Close $254.57    52 Week High $139.79 
Open $254.99    52 Week Low $82.07 
Day High $259.03    P/E 594.28 
Day Low $250.49    EPS $0.43 
Volume 247,086